The Hydration Pharmaceuticals Co (ASX:HPC) Retained Earnings: A$-65.12 Mil (As of Dec. 2025)


What is The Hydration Pharmaceuticals Co Retained Earnings?

The Hydration Pharmaceuticals Co ASX:HPC Retained Earnings is A$-65.12 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. The Hydration Pharmaceuticals Co's retained earnings for the quarter that ended in Dec. 2025 was A$-65.12 Mil.

The Hydration Pharmaceuticals Co's quarterly retained earnings increased from Dec. 2024 (A$-63.81 Mil) to Jun. 2025 (A$-41.99 Mil) but then declined from Jun. 2025 (A$-41.99 Mil) to Dec. 2025 (A$-65.12 Mil).

The Hydration Pharmaceuticals Co's annual retained earnings increased from Dec. 2023 (A$-64.36 Mil) to Dec. 2024 (A$-63.81 Mil) but then declined from Dec. 2024 (A$-63.81 Mil) to Dec. 2025 (A$-65.12 Mil).

The Hydration Pharmaceuticals Co  (ASX:HPC) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

The Hydration Pharmaceuticals Co Retained Earnings Historical Data

* Premium members only.

The historical data trend for The Hydration Pharmaceuticals Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Hydration Pharmaceuticals Co Retained Earnings Chart

The Hydration Pharmaceuticals Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
-34.09 -51.83 -64.36 -63.81 -65.12

The Hydration Pharmaceuticals Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Retained Earnings Get a 7-Day Free Trial Premium Member Only -64.36 -46.50 -63.81 -41.99 -65.12

The Hydration Pharmaceuticals Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of A$-65.12 Mil mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a Retained Earnings of A$-65.12 Mil as of Dec. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on The Hydration Pharmaceuticals Co and its competitors.
Is The Hydration Pharmaceuticals Co's Retained Earnings too high?
The Hydration Pharmaceuticals Co's current Retained Earnings is A$-65.12 Mil.
How does The Hydration Pharmaceuticals Co's Retained Earnings compare to SYY and USFD?
The Hydration Pharmaceuticals Co's Retained Earnings of A$-65.12 Mil can be compared against companies in the Retail - Defensive industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Retail - Defensive company?
A good Retained Earnings depends on the Retail - Defensive industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on The Hydration Pharmaceuticals Co and its competitors. The Hydration Pharmaceuticals Co's current Retained Earnings is A$-65.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Retained Earnings of A$-65.12 Mil. The current Retained Earnings is A$-65.12 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Retained Earnings is A$-65.12 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Hydration Pharmaceuticals Co Business Description

Address 6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.